Skip to main content
Figure 3 | BMC Genomics

Figure 3

From: Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data

Figure 3

The 90-gene meta-signature achieves similar or better performance than the individually optimized signatures. A and E compare the Kaplan-Meier curves stratified by high versus low risk group predicted by the study-specific signature and by the meta-signature respectively in the Sorlie study cohort; B and F show similar comparison in the van't Veer study cohort; C and G show similar comparison in the Sotiriou study cohort; and D and H show comparison in the Huang study cohort.

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us